4.6 Review

DNA Methylation Dynamics in the Female Germline and Maternal-Effect Mutations That Disrupt Genomic Imprinting

期刊

GENES
卷 12, 期 8, 页码 -

出版社

MDPI
DOI: 10.3390/genes12081214

关键词

oocyte; epigenetics; genomic imprinting; DNA methylation; subcortical maternal complex; embryo arrest; infertility; epimutations

资金

  1. UK Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0423]
  2. Medical Research Council [MR/S000437/1]
  3. People Programme (Marie Curie Actions) of the European Union's H2020 Programme [PITN-GA-2019-860960]
  4. Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [R01HD079442, R01HD092746]
  5. Intellectual and Developmental Disabilities Research Center (IDDRC) [P50 HD103555]
  6. Lalor Foundation, INC
  7. BBSRC [BBS/E/B/000C0423] Funding Source: UKRI
  8. MRC [MR/S000437/1] Funding Source: UKRI

向作者/读者索取更多资源

Genomic imprinting is an epigenetic process affecting development, with multi-locus imprinting disturbances possibly leading to disorders. Pathogenic gene variants can cause rare embryonic and reproductive issues.
Genomic imprinting is an epigenetic marking process that results in the monoallelic expression of a subset of genes. Many of these 'imprinted' genes in mice and humans are involved in embryonic and extraembryonic growth and development, and some have life-long impacts on metabolism. During mammalian development, the genome undergoes waves of (re)programming of DNA methylation and other epigenetic marks. Disturbances in these events can cause imprinting disorders and compromise development. Multi-locus imprinting disturbance (MLID) is a condition by which imprinting defects touch more than one locus. Although most cases with MLID present with clinical features characteristic of one imprinting disorder. Imprinting defects also occur in 'molar' pregnancies-which are characterized by highly compromised embryonic development-and in other forms of reproductive compromise presenting clinically as infertility or early pregnancy loss. Pathogenic variants in some of the genes encoding proteins of the subcortical maternal complex (SCMC), a multi-protein complex in the mammalian oocyte, are responsible for a rare subgroup of moles, biparental complete hydatidiform mole (BiCHM), and other adverse reproductive outcomes which have been associated with altered imprinting status of the oocyte, embryo and/or placenta. The finding that defects in a cytoplasmic protein complex could have severe impacts on genomic methylation at critical times in gamete or early embryo development has wider implications beyond these relatively rare disorders. It signifies a potential for adverse maternal physiology, nutrition, or assisted reproduction to cause epigenetic defects at imprinted or other genes. Here, we review key milestones in DNA methylation patterning in the female germline and the embryo focusing on humans. We provide an overview of recent findings regarding DNA methylation deficits causing BiCHM, MLID, and early embryonic arrest. We also summarize identified SCMC mutations with regard to early embryonic arrest, BiCHM, and MLID.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据